Volume 07| July 11, 2018
RxReins is a dedicated Managing General Underwriter (MGU) specializing in prescription stop loss insurance for group benefit plans. We work closely with Brokers, TPAs and PBMs to provide the best available products from multiple A-rated carriers in all fifty states . RxReins is a member of the ELMC Risk Solutions family of companies.
MONTHLY NEWS AND UPDATES!
PRICE CHECK ON DRUG ADS: WOULD REVEALING COSTS HELP PATIENTS CONTROL SPENDING?

" Apart from legal questions about whether the  Food and Drug Administration has the authority to require pricing in ads, other uncertainties arise. For example, what is the right number to use? There is a dizzying array of ways to look at drug prices, including average wholesale and average sales prices, and dosage factors. Would the price be pegged to a monthly cost? A per-dose cost? Or, even more inscrutable, a “unit cost,” which may not equal a single dose? "

ADMINISTRATION EASES WAY FOR SMALL BUSINESS TO BUY INSURANCE IN BULK

"Small employers will more easily be able to band together to buy health insurance under  rules issued Tuesday , but the change could raise premiums for plans sold through the Affordable Care Act’s online marketplaces, analysts say. The move loosens restrictions on so-called association health plans, allowing more businesses, including sole proprietors, to join forces to buy health coverage in bulk for their workers. Supporters say the new Labor Department rules, which the government estimated could create health plans covering as many as 11 million people, will lead to more affordable choices for some employers."

FDA APPROVES DRUG IN COMBINATION WITH CHEMOTHERAPY FOR OVARIAN CANCER

" The US Food and Drug Administration has approved a drug in combination with chemotherapy for the treatment of women with ovarian cancer.The approval was based on the phase III GOG-0218 trial, in which women with previously untreated stage III or IV epithelial ovarian, primary peritoneal, or fallopian tube carcinoma who already had surgery received chemotherapy alone (carboplatin and paclitaxel), Avastin (15 mg/kg) plus chemotherapy followed by placebo alone, or Avastin plus chemotherapy followed by Avastin alone for a total of up to 22 cycles. "


Looking for a Rx Stop Loss Quote?

Here's a list of items we require in order to prepare an Aggregate or Guaranteed Cost proposal:

  1.  A completed copy of our RFQ form (click the link below for a copy)
  2. 12 months of most recent claims and enrollment data by month
  3. A Top 25 Drugs by Cost report
  4. A current copy of the group’s SPD or Plan Document to verify the Prescription Drug plan design

* If detailed claim data is available for the group, we like to see this as well.
To learn more, sign up for our webinar or visit our website . RxReins.com
RxReins, LLC | 888.797.3467 | Stoploss@Rxreins.coml | www.rxreins.com